- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03990116
Efficacy of Lateral Kangaroo Care in Hemodynamic Stabilization of Premature Infant. (Cangulat)
Efficacy of Lateral Kangaroo Care in Hemodynamic Stabilization of Premature Infant
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A non-inferiority clinical trial, controlled, randomized and not blinded has been designed. The non-equivalent, experimental group consist on neonates less than 28 weeks of gestational age who are placed in lateral position while they are on kangaroo care during the first 5 days of life. On the other hand, the control group include neonates less than 28 weeks of gestational age who are in traditional prone position during kangaroo care on the first 5 days of life.
To define the sample size a power of 80% is assumed (β=0,20) and a 95% confidence interval (α=0,05) with a difference of 0,3ºC (SD 0,16) (9,10) in the axillary temperature. A non inferiority margin of 0.2ºC is established and a 10% sample size loss has been assumed. So a sample size of 35 premature in each group has been estimated.
A non probabilistic and consecutive sampling has been defined. The allocation into the experimental (lateral position) or control group (prone position) is going to be randomized.
The main outcome variable is the axillary temperature. However other clinical variables as pain, changes in the vital signs, HIV incidence rate are going to be measured as well.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Laura Collados, PhD
- Phone Number: +34686822609
- Email: laura.collados@salud.madrid.org
Study Locations
-
-
-
Madrid, Spain, 28030
- Recruiting
- Laura Collados Gómez
-
Contact:
- Laura Collados Gómez, phD
- Phone Number: 686822609
- Email: laura.collados@salud.madrid.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Premature under 28 weeks of gestational age with mother / father who wants kangaroo care.
Exclusion Criteria:
- Premature infants with mechanical ventilation in high frequency mode,
- Premature infants in the immediate postoperative period of major surgery,
- Premature infants with malformations of the abdominal Wall
- Premature infants who require immobilization
- Premature infants who do not tolerate kangaroo care: hemodynamic, thermal instability or increased stress
- Premature infants with duration of kangaroo care of less than 60 minutes.
- Also excluded are those patients where the kangaroo care provider has an anatomical limitation for carrying out kangaroo care.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lateral kangaroo
Placing the infant in lateral on the parents chest, keeping the head neutral and limbs flexed towards body midline
|
Posture lateral kangaroo care
|
Active Comparator: Prone Kangaroo
placing the baby in upright and ventral position between mother's breasts or over the father chest, in skin-to skin contact with no clothes in between and with lower limbs flexed
|
Posture prone kangaroo care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from skin temperature
Time Frame: T0: baseline; T1: 30 minutes after to start kangaroo care; T2: 30 minutes after to finish kangaroo care
|
Change from skin temperature after kangaroo care Peripheral temperature of the premature measured in the axilla with Braun® PRT2000 thermometer and the continuous temperature monitoring sensor of Giraffe ® incubators (AirLife TM infant skin temperature probe)
|
T0: baseline; T1: 30 minutes after to start kangaroo care; T2: 30 minutes after to finish kangaroo care
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Laura Collados, phD, Hospital Universitario 12 de octubre
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NEO_nur_19
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Infant
-
University of MiamiPontificia Universidad Catolica de ChileTerminated
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedInfant, Premature | Infant, Newborn
-
NICHD Neonatal Research NetworkNational Center for Research Resources (NCRR)CompletedSepsis | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, NewbornUnited States
-
Aydin Adnan Menderes UniversityCompletedNursing Caries | Infant Development | Premature Infant Disease | Patient ComfortTurkey
-
University of VirginiaRecruitingDevelopment, Infant | Premature Infant DiseaseUnited States
-
Universidad de LeónCompletedPremature Birth | Premature Infant | Massage | Preterm Infant
-
Istituto Giannina GasliniEubrainRecruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedPreterm Birth | Cerebral Autoregulation | Premature Infant DiseaseItaly
-
Sun Yat-sen UniversityRecruitingPremature Infant DiseaseChina
-
Instituto Nacional de Perinatologia Isidro Espinosa...UnknownImmune System Diseases | Premature Infant Disease | Immunoglobulin DeficiencyMexico
Clinical Trials on Lateral
-
Sergio Thal, M.D.Medtronic; Lexington VA Medical CenterUnknownHeart Failure | Cardiac Resynchronization TherapyUnited States
-
Shahid Beheshti University of Medical SciencesUnknownStrabismusIran, Islamic Republic of
-
University of PernambucoUniversidade Federal de Pernambuco; Coordination for the Improvement of Higher... and other collaboratorsCompletedHealthy IndividualsBrazil
-
Laval UniversityFonds de la Recherche en Santé du Québec; Natural Sciences and Engineering... and other collaboratorsCompleted
-
Universidad Europea de MadridCompleted
-
University of British ColumbiaPedorthic Research Foundation of Canada; Kintec FootlabsCompletedKnee OsteoarthritisCanada
-
Sohag UniversityNot yet recruitingDegenerative Cervical Myelopathy (DCM)
-
Changhai HospitalCompleted
-
National Institute of Respiratory Diseases, MexicoHospital General Dr. Manuel Gea González; National Institute of Medical Sciences... and other collaboratorsNot yet recruitingAcquired Immunodeficiency Syndrome | Cryptococcal Meningitis | Tuberculosis Infection | Histoplasmosis AIDSMexico